A recent study that integrated neuroimaging with transcriptomic gene expression analyses in patients with MDD undergoing ECT revealed a correlation between increased gray matter volume and higher expression levels of MDD risk genes, including CNR1, HTR1A, MAOA, PDE1A, and SST. Here, HTR1A is linked to major depressive disorder.